OQROGet OQRO Pro
Insider trade

Agios Pharmaceuticals (AGIO)CEO sold ~$209K

Brian Goff, CEO at Agios Pharmaceuticals, sold ~$209K of Agios Pharmaceuticals shares.

~$209K
Approx. value · 6,229 sh @ $33.54
112K
Holds after · shares reported
Traded
Jun 24, 2025
Filed
Jun 26, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Apr 17, 2025CongressDisclosed purchase of AGIO — reported range $1,001 - $15,000
  2. Jun 24, 2025 · this disclosureInsiderCEO sold ~$209K of AGIO shares in the open market

What came next

  1. Jun 24, 2025Insider · 5 peopleInsiders: 5 sales (~$762K)
  2. Jul 1, 2025InsiderOfficer sold ~$140K of AGIO shares in the open market
  3. Jul 9, 2025Insider · 1 personInsiders: 2 sales (~$453K)
  4. Jul 10, 2025InsiderDirector sold ~$56K of AGIO shares in the open market
  5. Aug 8, 2025InsiderCEO sold ~$406K of AGIO shares in the open market
  6. Aug 27, 2025InsiderDirector sold ~$8K of AGIO shares in the open market
  7. Sep 5, 2025InsiderOfficer sold ~$315K of AGIO shares in the open market
  8. Sep 26, 2025InsiderCFO sold ~$134K of AGIO shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Agios Pharmaceuticals

For Agios Pharmaceuticals, OQRO holds 1 Congress trade report, 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AGIO page.

Other recent filings by Brian Goff, Chief Executive Officer

The full history of Brian Goff, Chief Executive Officer is on the profile page.

How this filing works

Other disclosures at Agios Pharmaceuticals

Everything OQRO holds on this company is on its AGIO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data